220 related articles for article (PubMed ID: 9040206)
1. A case series of transplant recipients who despite immunosuppression developed inflammatory bowel disease.
Riley TR; Schoen RE; Lee RG; Rakela J
Am J Gastroenterol; 1997 Feb; 92(2):279-82. PubMed ID: 9040206
[TBL] [Abstract][Full Text] [Related]
2. Five cases of de novo inflammatory bowel disease after orthotopic liver transplantation.
Wörns MA; Lohse AW; Neurath MF; Croxford A; Otto G; Kreft A; Galle PR; Kanzler S
Am J Gastroenterol; 2006 Aug; 101(8):1931-7. PubMed ID: 16790037
[TBL] [Abstract][Full Text] [Related]
3. The safety and efficacy of antitumour necrosis factor-alpha therapy for inflammatory bowel disease in patients post liver transplantation: a case series.
Sandhu A; Alameel T; Dale CH; Levstik M; Chande N
Aliment Pharmacol Ther; 2012 Jul; 36(2):159-65. PubMed ID: 22616981
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory bowel disease following solid organ transplantation.
Hampton DD; Poleski MH; Onken JE
Clin Immunol; 2008 Sep; 128(3):287-93. PubMed ID: 18708022
[TBL] [Abstract][Full Text] [Related]
6. Outcome of cytomegalovirus infections in patients with inflammatory bowel disease.
Papadakis KA; Tung JK; Binder SW; Kam LY; Abreu MT; Targan SR; Vasiliauskas EA
Am J Gastroenterol; 2001 Jul; 96(7):2137-42. PubMed ID: 11467645
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory bowel disease after liver transplantation: a role for cytomegalovirus infection.
Verdonk RC; Haagsma EB; Van Den Berg AP; Karrenbeld A; Slooff MJ; Kleibeuker JH; Dijkstra G
Scand J Gastroenterol; 2006 Feb; 41(2):205-11. PubMed ID: 16484126
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
Maggiore G; Riva S; Sciveres M
Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
[TBL] [Abstract][Full Text] [Related]
9. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?
Bayraktar Y; Arslan S; Saglam F; Uzunalimoglu B; Kayhan B
Hepatogastroenterology; 1998; 45(24):2064-72. PubMed ID: 9951867
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E
P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
[TBL] [Abstract][Full Text] [Related]
11. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
12. The association between corticosteroid use and development of fractures among IBD patients in a population-based database.
Bernstein CN; Blanchard JF; Metge C; Yogendran M
Am J Gastroenterol; 2003 Aug; 98(8):1797-801. PubMed ID: 12907335
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for abnormal liver function tests in patients with ileal pouch-anal anastomosis for underlying inflammatory bowel disease.
Navaneethan U; Remzi FH; Nutter B; Fazio VW; Shen B
Am J Gastroenterol; 2009 Oct; 104(10):2467-75. PubMed ID: 19550410
[TBL] [Abstract][Full Text] [Related]
14. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
15. Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine.
Korelitz BI; Mirsky FJ; Fleisher MR; Warman JI; Wisch N; Gleim GW
Am J Gastroenterol; 1999 Nov; 94(11):3248-53. PubMed ID: 10566724
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease.
Jørgensen KK; Lindström L; Cvancarova M; Karlsen TH; Castedal M; Friman S; Schrumpf E; Foss A; Isoniemi H; Nordin A; Holte K; Rasmussen A; Bergquist A; Vatn MH; Boberg KM
Clin Gastroenterol Hepatol; 2013 May; 11(5):517-23. PubMed ID: 23333218
[TBL] [Abstract][Full Text] [Related]
17. Surgical outcome in patients with primary sclerosing cholangitis undergoing ileal pouch-anal anastomosis: a case-control study.
Gorgun E; Remzi FH; Manilich E; Preen M; Shen B; Fazio VW
Surgery; 2005 Oct; 138(4):631-7; discussion 637-9. PubMed ID: 16269291
[TBL] [Abstract][Full Text] [Related]
18. Carcinoid tumor and inflammatory bowel disease: a study of eleven cases and review of the literature.
Greenstein AJ; Balasubramanian S; Harpaz N; Rizwan M; Sachar DB
Am J Gastroenterol; 1997 Apr; 92(4):682-5. PubMed ID: 9128324
[TBL] [Abstract][Full Text] [Related]
19. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
[TBL] [Abstract][Full Text] [Related]
20. [Clinical course of inflammatory bowel disease in patients transplanted for primary sclerosing cholangitis].
Villamil A; De Paula JA; Galdame O; Piccioni H; Ciardullo M; De Santibañes E; Gadano A
Acta Gastroenterol Latinoam; 2008 Dec; 38(4):252-9. PubMed ID: 19157380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
